International- About Us
- What We Do
- Science
- Outwit HIV Where it Hits the Most
- Structure and Governance of VISTA
- VISTA Scientific Strategy Group
- VISTA Program Steering Group
- Clinical Research Centers in Africa
- VISTA, Vaccine Immunology Science and Technology for Africa
- Science
- Human Immunology Lab
- Clinical Research Centers
- Clinical Research Standards
- Capacity Building
- Progress
- IAVI Portfolio
- HIV Vaccine Approaches
- Advocacy
- How Discordant Couples and HIV Vaccine Research Benefit from Each Other
- AIDS Vaccine Research Brings Hope to Underserved Ugandan Fishing Communities
- Why Women and Girls Need an AIDS Vaccine
- HIV Vaccine Research in Kenya Yields Better Healthcare, Less Stigma and Empowerment for Men Who Have Sex with Men
- Community Engagement
- Advocacy
- Mobilize
- Ensuring Access
- Partner
- Science
- Where We Work
- Who We Are
- Leaders
- Experts
- Our Studies
- Policy Research
- Social Science Research
- Social Science Research
- An exploratory study of fishing communities in Uganda to determine suitability as candidate populations for HIV-prevention trials
- Ensuring quality of services in HIV-prevention research settings: findings from a multi-center quality improvement pilot in East Africa
- New vaccine introduction in Tamil Nadu: a case study of the HPV vaccine
- Barriers and opportunities for involving MSM and transgender (TG) communities in HIV-prevention research in four cities in India
- AIDS vaccine research participation in Kenya: understanding gender-related barriers and social impact
- Social Science Research
- Observational Epidemiology
- Clinical Trials
- Clinical Trials
- IPCAVD009
- IAVI R001
- IDEA EV06
- N004 (HIVCORE 004)
- X001
- PAVE 100
- IAVI V002
- IAVI 006
- IAVI B004
- IAVI B002
- IAVI B003
- IAVI C001
- IAVI 009
- IAVI 008
- IAVI 005
- IAVI 004
- IAVI 003
- IAVI 016
- IAVI P001
- IAVI B001
- IAVI V001
- IAVI D001
- IAVI C004/DHO-614
- IAVI C003
- IAVI C002
- IAVI A002
- IAVI A001
- IAVI 011
- IAVI 010
- IAVI 002
- IAVI P002
- IAVI 001
- IAVI N004/ HIV-CORE 004
- IAVI A003
- IAVI S001
- Clinical Trials
- Our Studies
- Leaders
- Experts
- Social Science Research
- An exploratory study of fishing communities in Uganda to determine suitability as candidate populations for HIV-prevention trials
- Ensuring quality of services in HIV-prevention research settings: findings from a multi-center quality improvement pilot in East Africa
- New vaccine introduction in Tamil Nadu: a case study of the HPV vaccine
- Barriers and opportunities for involving MSM and transgender (TG) communities in HIV-prevention research in four cities in India
- AIDS vaccine research participation in Kenya: understanding gender-related barriers and social impact
- Observational Epidemiology
- Clinical Trials
- IPCAVD009
- IAVI R001
- IDEA EV06
- N004 (HIVCORE 004)
- X001
- PAVE 100
- IAVI V002
- IAVI 006
- IAVI B004
- IAVI B002
- IAVI B003
- IAVI C001
- IAVI 009
- IAVI 008
- IAVI 005
- IAVI 004
- IAVI 003
- IAVI 016
- IAVI P001
- IAVI B001
- IAVI V001
- IAVI D001
- IAVI C004/DHO-614
- IAVI C003
- IAVI C002
- IAVI A002
- IAVI A001
- IAVI 011
- IAVI 010
- IAVI 002
- IAVI P002
- IAVI 001
- IAVI N004/ HIV-CORE 004
- IAVI A003
- IAVI S001
- Social Science Research
- Partners
- How To Help
- IAVI Trials Database
- Media Center
- Donate Now
